Urate and Its Transgenic Depletion Modulate Neuronal Vulnerability in a Cellular Model of Parkinson's Disease

by Cipriani, Sara, Desjardins, Cody A., Burdett, Thomas C., Xu, Yuehang, Xu, Kui, Schwarzschild, Michael A.
Published 2012

Particulate matter and risk of parkinson disease in a large prospective study of women

by Palacios, Natalia, Fitzgerald, Kathryn C, Hart, Jaime E, Weisskopf, Marc G, Schwarzschild, Michael A, Ascherio, Alberto, Laden, Francine
Published 2014

A Prospective Analysis of Airborne Metal Exposures and Risk of Parkinson Disease in the Nurses’ Health Study Cohort

by Palacios, Natalia, Fitzgerald, Kathryn, Roberts, Andrea L., Hart, Jaime E., Weisskopf, Marc G., Schwarzschild, Michael A., Ascherio, Alberto, Laden, Francine
Published 2014

Chronic Treatment with Novel Small Molecule Hsp90 Inhibitors Rescues Striatal Dopamine Levels but Not α-Synuclein-Induced Neuronal Cell Loss

by McFarland, Nikolaus R., Dimant, Hemi, Kibuuka, Laura, Ebrahimi-Fakhari, Darius, Desjardins, Cody A., Danzer, Karin M., Danzer, Michael, Fan, Zhanyun, Schwarzschild, Michael A., Hirst, Warren, McLean, Pamela J.
Published 2014

Linked Clinical Trials – The Development of New Clinical Learning Studies in Parkinson’s Disease Using Screening of Multiple Prospective New Treatments

by Brundin, Patrik, Barker, Roger A., Conn, P. Jeffrey, Dawson, Ted M., Kieburtz, Karl, Lees, Andrew J., Schwarzschild, Michael A., Tanner, Caroline M., Isaacs, Tom, Duffen, Joy, Matthews, Helen, Wyse, Richard K.H.
Published 2013

The Sirtuin-2 Inhibitor AK7 Is Neuroprotective in Models of Parkinson’s Disease but Not Amyotrophic Lateral Sclerosis and Cerebral Ischemia

by Chen, Xiqun, Wales, Pauline, Quinti, Luisa, Zuo, Fuxing, Moniot, Sébastien, Herisson, Fanny, Rauf, Nazifa Abdul, Wang, Hua, Silverman, Richard B., Ayata, Cenk, Maxwell, Michelle M., Steegborn, Clemens, Schwarzschild, Michael A., Outeiro, Tiago F., Kazantsev, Aleksey G.
Published 2015